Who Should Attend

• Clinicians → neurology, psychiatry, and preventative cognitive care
• Pharma & Biotech → advancing neuroscience research, developing innovative therapeutics, and scaling solutions for cognitive health and neurodegenerative disease across the life course
• Insurance Providers → coverage models and reimbursement for cognitive interventions
  
• Policy and Advocacy Leaders → brain health equity, public awareness, and policy
• Corporate Health and Wellness Leaders → evaluating brain health solutions for employee benefits, productivity, burnout prevention, and midlife attrition prevention
  
• Startups → digital therapeutics and neurotech
• Investors → brain health, neurodegeneration, and longevity innovation

Key Topics

Focus: Brain health across life stages, reducing midlife workforce attrition, and advancing corporate health benefits

• Wearables → tracking devices for monitoring brain health, sleep, focus, and cognitive load
• Prevention and Early Intervention → reducing risk of dementia, Alzheimer’s disease, and cognitive decline
• Access and Equity → addressing disparities in diagnosis, care, and research representation
• Policy and Advocacy → positioning brain health as a public health priority, insurance coverage, and research funding
• Clinical and Workplace Interventions → evidence based cognitive care, digital first models, and employer led programs
• Investment Opportunities → early stage cognitive health startups and longevity markets